Eastwood Bio-Medical Canada Inc. (TSXV:EBM)
Canada flag Canada · Delayed Price · Currency is CAD
1.000
-0.090 (-9.00%)
Feb 9, 2026, 11:28 AM EST

TSXV:EBM Income Statement

Millions CAD. Fiscal year is Nov - Oct.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Jul '25 Oct '24 Oct '23 Oct '22 Oct '21 Oct '20
0.590.70.871.30.980.72
Revenue Growth (YoY)
-9.02%-19.11%-33.22%32.49%36.57%-44.44%
Cost of Revenue
0.210.250.320.40.520.54
Gross Profit
0.380.450.550.90.460.18
Selling, General & Admin
0.650.720.910.90.921.03
Amortization of Goodwill & Intangibles
0.070.110.110.110.110.11
Operating Expenses
0.720.841.021.011.031.14
Operating Income
-0.34-0.38-0.47-0.11-0.57-0.96
Interest Expense
-0.01-0.01-0.03-0.01-0-
Interest & Investment Income
-----0
Currency Exchange Gain (Loss)
-0.01-0.01-0.01-0.01--
Other Non Operating Income (Expenses)
-0.05-0.06-0.03-0.02-0.05-0.04
EBT Excluding Unusual Items
-0.41-0.46-0.55-0.15-0.62-0.99
Other Unusual Items
----0.020.14
Pretax Income
-0.41-0.46-0.55-0.15-0.6-0.85
Net Income
-0.41-0.46-0.55-0.15-0.6-0.85
Net Income to Common
-0.41-0.46-0.55-0.15-0.6-0.85
Shares Outstanding (Basic)
696969696969
Shares Outstanding (Diluted)
696969696969
EPS (Basic)
-0.01-0.01-0.01-0.00-0.01-0.01
EPS (Diluted)
-0.01-0.01-0.01-0.00-0.01-0.01
Free Cash Flow
0.02-0.02-0.02-0.01-0.12-0.54
Free Cash Flow Per Share
-----0.00-0.01
Gross Margin
63.91%64.72%63.18%69.45%46.72%25.00%
Operating Margin
-58.02%-54.24%-54.42%-8.60%-58.07%-133.15%
Profit Margin
-69.27%-64.93%-62.98%-11.53%-61.52%-118.67%
Free Cash Flow Margin
3.54%-2.17%-1.95%-0.56%-12.41%-75.55%
EBITDA
-0.33-0.33-0.42-0.06-0.52-0.91
EBITDA Margin
-55.85%-47.43%-48.87%-4.97%-53.42%-126.75%
D&A For EBITDA
0.010.050.050.050.050.05
EBIT
-0.34-0.38-0.47-0.11-0.57-0.96
EBIT Margin
-58.02%-54.24%-54.42%-8.60%-58.07%-133.15%
Revenue as Reported
0.590.70.871.30.980.72
Advertising Expenses
-0000.020.03
Source: S&P Global Market Intelligence. Standard template. Financial Sources.